Mtb bacteria detected in exhaled breath of 90% of individuals presenting with suspected tuberculosis

Mycobacterium tuberculosis (Mtb), the bacteria that causes a tuberculosis infection, is present in exhaled breath of 90% of those presenting with suspected tuberculosis.

Expert Guide to Compound Medication Pharmacies and Companies

Compound medication pharmacies and companies: Introduction In the intricate landscape of global healthcare, compound medication stands as a bespoke solution to patient-specific needs. As the

May 31, 2024

EC grants marketing authorisation to BridgeBio’s Beyonttra

The therapy has demonstrated significant benefits in cardiovascular outcomes. Credit: Jo Panuwat D/Shutterstock. The European Commission (EC) has granted marketing authorisation to BridgeBio Pharma’s selective

February 12, 2025

PF-08046054 by Pfizer for Solid Tumor: Likelihood of Approval

PF-08046054 is under clinical development by Pfizer and currently in Phase I for Solid Tumor.

February 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.